Finally, although we established a link between METTL3 O-GlcNAcylation and the initiation of liver cancer, the extent of its influence on advanced HCC stages and its significance in the context of anti-cancer therapeutics remain to be determined. Here, METTL3 is linked to hepatocellular carcinoma.